Skip to main content
SpringerLink
Log in

Prolactin secretion is not a core dimension of “atypicality”

  • Letter to the editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Benkert O, Holsboer F (1984) Effect of sulpiride in endogenous depression. Acta Psychiatr Scand Suppl 311:43–48

    Article  CAS  PubMed  Google Scholar 

  • Boyer P, Lecrubier Y, Puech AJ, Dewailly J, Aubin F (1995) Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 166:68–72

    Article  CAS  PubMed  Google Scholar 

  • Gründer G, Wetzel H, Hillert A, Jochum E, Hiemke C, Benkert O (1995) The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients. Psychopharmacology 117:472–478

    Article  PubMed  Google Scholar 

  • Gründer G, Wetzel H, Schlösser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O (1999) Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 45:89–97

    Article  PubMed  Google Scholar 

  • Meltzer HY (2000) An atypical compound by any other name is still a... Psychopharmacology 148:16–19

    Article  CAS  PubMed  Google Scholar 

  • Müller MJ, Wetzel H, Benkert O (1998) Differential treatment effects of amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia. Schizophr Res 29:157–158

    Article  Google Scholar 

  • Remington G, Kapur S (2000) Atypical antipsychotics: are some more atypical than others? Psychopharmacology 148:3–15

    Article  CAS  PubMed  Google Scholar 

  • Stille G, Hippius H (1971) Kritische Stellungnahme zum Begriff der Neuroleptica (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmakopsychiatr Neuropsychopharmakol 4:182–191

    Article  CAS  Google Scholar 

  • Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schroder J, Rein W, Benkert O (1998) Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group. Psychopharmacology 137:223–232

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Mainz, Untere Zahlbacher Strasse 8, 55131, Mainz, Germany

    Gerhard Gründer & Otto Benkert

Authors
  1. Gerhard Gründer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerhard Gründer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gründer, G., Benkert, O. Prolactin secretion is not a core dimension of “atypicality”. Psychopharmacology 162, 93 (2002). https://doi.org/10.1007/s00213-002-1066-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1066-6

Keywords

Search

Navigation